BiondVax Pharmaceuticals Ltd.
BVXV
NASDAQ Capital Market1.36
USD
+0.01
- -
Total Valuation
BiondVax Pharmaceuticals Ltd. carries a market capitalization of 4.97M, placing it among publicly traded companies globally.
| Market Cap | 4.97M |
| Enterprise Value | N/A |
Stock Price Statistics
BiondVax Pharmaceuticals Ltd.'s stock has declined approximately -80.43165% over the past 52 weeks. The 50-day moving average sits at 1.17, while the 200-day moving average is 1.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -80.43165% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.79 |
| Average Volume (20 Days) | N/A |
Stock Splits
BiondVax Pharmaceuticals Ltd.'s most recent stock split took place on November 25, 2022 with a 10:1 split ratio.
| Last Split Date | 11/25/2022 |
| Split Ratio | 10:1 |